• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Kinase Drugs

Kinase Drugs

Hardcover

Series: Wiley Drug Discovery and Development

Medical Reference

ISBN10: 0470278293
ISBN13: 9780470278291
Publisher: John Wiley & Sons
Published: Nov 1 2009
Pages: 544
Weight: 1.90
Height: 1.10 Width: 6.20 Depth: 9.30
Language: English

A comprehensive resource on case studies of marketed kinase drugs and promising drug trials

Since the discovery of protein kinase activity in 1954, the field of protein kinase drug discovery has advanced dramatically. With the ongoing clinical success of the Bcr-Abl kinase inhibitor Gleevec in the treatment of chronic myelogenous leukemia and seven additional marketed kinase inhibitor drugs, researchers have compelling evidence that kinase inhibitors can be highly efficacious in the treatment of diseases caused by aberrant activity of protein kinase. Currently more than 100 protein kinase inhibitors are in clinical development.

Also from

Li

Also in

Medical Reference